Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2015, Article ID 309042, 8 pages
http://dx.doi.org/10.1155/2015/309042
Research Article

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis

1Department of Hepatology, National Liver Institute, Menoufia University, Shebeen El-Kom, Egypt
2Department of Clinical Pathology, National Liver Institute, Menoufia University, Shebeen El-Kom, Egypt

Received 13 July 2015; Revised 17 September 2015; Accepted 17 September 2015

Academic Editor: Daisuke Morioka

Copyright © 2015 Mahmoud Omar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Slack, A. Yeoman, and J. Wendon, “Renal dysfunction in chronic liver disease,” Critical Care, vol. 14, no. 2, article 214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Arroyo, J. Fernandez, and P. Ginès, “Pathogenesis and treatment of hepatorenal syndrome,” Seminars in Liver Disease, vol. 28, no. 1, pp. 81–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Takabatake, H. Ohta, Y.-I. Ishida, H. Hara, Y. Ushiogi, and N. Hattori, “Low serum creatinine levels in severe hepatic disease,” Archives of Internal Medicine, vol. 148, no. 6, pp. 1313–1315, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Slack and J. Wendon, “The liver and kidney in critically ill patients,” Blood Purification, vol. 28, no. 2, pp. 124–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Cholongitas, V. Shusang, L. Marelli et al., “Review article: renal function assessment in cirrhosis—difficulties and alternative measurements,” Alimentary Pharmacology and Therapeutics, vol. 26, no. 7, pp. 969–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. L. Proulx, A. Akbari, A. X. Garg, A. Rostom, J. Jaffey, and H. D. Clark, “Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis,” Nephrology Dialysis Transplantation, vol. 20, no. 8, pp. 1617–1622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. MacAulay, K. Thompson, B. A. Kiberd, D. C. Barnes, and K. M. Peltekian, “Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?” Canadian Journal of Gastroenterology, vol. 20, no. 8, pp. 521–526, 2006. View at Google Scholar · View at Scopus
  8. L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey, “Assessing kidney function—measured and estimated glomerular filtration rate,” The New England Journal of Medicine, vol. 354, no. 23, pp. 2473–2483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Kandasamy, R. Smith, and I. M. R. Wright, “Measuring cystatin C to determine renal function in neonates,” Pediatric Critical Care Medicine, vol. 14, no. 3, pp. 318–322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. B. Dhia, I. Hellara, O. Harzallah et al., “Evaluation of the renal function in type 2 diabetes: clearance calculation or cystatin C?” Annales de Biologie Clinique, vol. 70, no. 3, pp. 287–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H.-X. Guo, C.-H. Wang, Z.-Q. Li et al., “The application of serum cystatin C in estimating the renal function in women with preeclampsia,” Reproductive Sciences, vol. 19, no. 7, pp. 712–717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Niemczyk, M. Piotrowska, and K. Szamotulska, “Usefulness of creatinine and cystatin C in the assessment of renal function in chronic kidney disease and coexisting diseases,” Polski Merkuriusz Lekarski, vol. 32, no. 191, pp. 313–317, 2012. View at Google Scholar · View at Scopus
  13. M. M. Sagheb, S. Namazi, B. Geramizadeh, A. Karimzadeh, M. B. Oghazian, and I. Karimzadeh, “Serum cystatin C as a marker of renal function in critically Ill patients with normal serum creatinine,” Nephro-Urology Monthly, vol. 6, no. 2, Article ID e15224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Suzuki, K. Matsushita, T. Yoshida, Y. Sawabe, and F. Nomura, “Clinical validity of renal function markers including serum cystatin C on chronic kidney disease classification,” Rinsho Byori, vol. 59, no. 4, pp. 345–351, 2011. View at Google Scholar · View at Scopus
  15. Y. Suzuki, M. Seimiya, T. Yoshida, Y. Sawabe, K. Matsushita, and F. Nomura, “Usefulness of the standardized serum cystatin C reagent in evaluation of renal function,” Rinsho Byori, vol. 61, no. 8, pp. 665–670, 2013. View at Google Scholar · View at Scopus
  16. K.-S. Woo, J.-L. Choi, B.-R. Kim, J.-E. Kim, and J.-Y. Han, “Clinical usefulness of serum cystatin C as a marker of renal function,” Diabetes and Metabolism Journal, vol. 38, no. 4, pp. 278–284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Đ. Ćulafić, “Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis,” World Journal of Gastroenterology, vol. 20, no. 21, pp. 6573–6579, 2014. View at Publisher · View at Google Scholar
  18. D. J. Kim, H. S. Kang, H. S. Choi et al., “Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels,” The Korean Journal of Hepatology, vol. 17, no. 2, pp. 130–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ustundag, K. Hekimoğlu, S. Ilikhan, G. Zaimoğlu, S. Acikgöz, and S. Aydemir, “Serum glucagon and cystatin C levels with renal doppler sonography findings in non-azotemic liver cirrhosis cases,” Hepato-Gastroenterology, vol. 58, no. 107-108, pp. 926–931, 2011. View at Google Scholar · View at Scopus
  20. D. Schuppan and N. H. Afdhal, “Liver cirrhosis,” The Lancet, vol. 371, no. 9615, pp. 838–851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. G. Child and J. G. Turcotte, “Surgery and portal hypertension,” Major problems in clinical surgery, vol. 1, pp. 1–85, 1964. View at Google Scholar · View at Scopus
  22. R. N. H. Pugh, I. M. Murray Lyon, and J. L. Dawson, “Transection of the oesophagus for bleeding oesophageal varices,” British Journal of Surgery, vol. 60, no. 8, pp. 646–649, 1973. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Wiesner, E. Edwards, R. Freeman et al., “Model for end-stage liver disease (MELD) and allocation of donor livers,” Gastroenterology, vol. 124, no. 1, pp. 91–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. B. A. C. van Acker, G. C. M. Koomen, M. G. Koopman, D. R. de Waart, and L. Arisz, “Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate,” The Lancet, vol. 340, no. 8831, pp. 1326–1329, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, no. 2, supplement 1, pp. S1–S266, 2002. View at Google Scholar
  28. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. L. A. Inker, C. H. Schmid, H. Tighiouart et al., “Estimating glomerular filtration rate from serum creatinine and cystatin C,” The New England Journal of Medicine, vol. 367, no. 1, pp. 20–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. S. Ahn, Y. S. Kim, S. G. Kim et al., “Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels,” Hepato-Gastroenterology, vol. 59, no. 116, pp. 1168–1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Ustundag, U. Samsar, S. Acikgoz et al., “Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 7, pp. 890–894, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Demirtaş, A. Bozbaş, A. Akbay, Y. Yavuz, and L. Karaca, “Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome,” Clinica Chimica Acta, vol. 311, no. 2, pp. 81–89, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Randers, P. Ivarsen, E. J. Erlandsen et al., “Plasma cystatin C as a marker of renal function in patients with liver cirrhosis,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 62, no. 2, pp. 129–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Adachi, A. Tanaka, M. Aiso, Y. Takamori, and H. Takikawa, “Benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis,” Hepatology Research, 2015. View at Publisher · View at Google Scholar
  35. P. Ginès and R. W. Schrier, “Renal failure in cirrhosis,” The New England Journal of Medicine, vol. 361, no. 13, pp. 1279–1290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Herget-Rosenthal, J. Metzger, A. Albalat, V. Bitsika, and H. Mischak, “Proteomic biomarkers for the early detection of acute kidney injury,” Prilozi, vol. 33, no. 1, pp. 27–48, 2012. View at Google Scholar
  37. D. P. O'Connor, M. T. Mahar, M. S. Laughlin, and A. S. Jackson, “The Bland-Altman method should not be used in regression cross-validation studies,” Research Quarterly for Exercise and Sport, vol. 82, no. 4, pp. 610–616, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. L. Gerbes, V. Gülberg, M. Bilzer, and M. Vogeser, “Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver,” Gut, vol. 50, no. 1, pp. 106–110, 2002. View at Publisher · View at Google Scholar · View at Scopus